These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19330779)

  • 1. A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.
    Iwatsuki M; Mimori K; Yokobori T; Tanaka F; Tahara K; Inoue H; Baba H; Mori M
    J Surg Oncol; 2009 Sep; 100(3):261-6. PubMed ID: 19330779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of TROP2 expression in colorectal cancer.
    Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
    Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
    Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
    Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.
    Seetharam RN; Sood A; Basu-Mallick A; Augenlicht LH; Mariadason JM; Goel S
    Anticancer Res; 2010 Jul; 30(7):2531-8. PubMed ID: 20682979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
    Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.
    Hao JM; Chen JZ; Sui HM; Si-Ma XQ; Li GQ; Liu C; Li JL; Ding YQ; Li JM
    J Pathol; 2010 Mar; 220(4):475-89. PubMed ID: 20077526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
    Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM
    Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis.
    Xiang G; Wen X; Wang H; Chen K; Liu H
    J Surg Oncol; 2009 Dec; 100(8):708-12. PubMed ID: 19777490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
    Meynard D; Le Morvan V; Bonnet J; Robert J
    Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.
    Ozawa H; Iwatsuki M; Mimori K; Sato T; Johansson F; Toh H; Watanabe M; Mori M
    Ann Surg Oncol; 2010 Sep; 17(9):2341-8. PubMed ID: 20339950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
    Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B; Peters G; Davey R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
    J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
    Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
    Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
    Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.